SG11202112276RA - Novel peptide compound or pharmaceutically acceptable salt thereof - Google Patents
Novel peptide compound or pharmaceutically acceptable salt thereofInfo
- Publication number
- SG11202112276RA SG11202112276RA SG11202112276RA SG11202112276RA SG11202112276RA SG 11202112276R A SG11202112276R A SG 11202112276RA SG 11202112276R A SG11202112276R A SG 11202112276RA SG 11202112276R A SG11202112276R A SG 11202112276RA SG 11202112276R A SG11202112276R A SG 11202112276RA
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- peptide compound
- novel peptide
- novel
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/54—Proteins
- A23V2250/55—Peptide, protein hydrolysate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Birds (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20190059628 | 2019-05-21 | ||
| PCT/KR2020/006594 WO2020235932A1 (ko) | 2019-05-21 | 2020-05-20 | 신규한 펩타이드 화합물 또는 이의 약제학적으로 허용 가능한 염 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202112276RA true SG11202112276RA (en) | 2021-12-30 |
Family
ID=73458705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202112276RA SG11202112276RA (en) | 2019-05-21 | 2020-05-20 | Novel peptide compound or pharmaceutically acceptable salt thereof |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP3974441A4 (zh) |
| JP (1) | JP2022533991A (zh) |
| KR (2) | KR20200134175A (zh) |
| CN (1) | CN114269769A (zh) |
| AU (1) | AU2020277930B2 (zh) |
| BR (1) | BR112021023477A2 (zh) |
| CA (1) | CA3139411A1 (zh) |
| MX (1) | MX2021014051A (zh) |
| SG (1) | SG11202112276RA (zh) |
| WO (1) | WO2020235932A1 (zh) |
| ZA (1) | ZA202109175B (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3139411A1 (en) * | 2019-05-21 | 2020-11-26 | Eyebio Korea | Novel peptide compound or pharmaceutically acceptable salt thereof |
| WO2023113300A1 (ko) * | 2021-12-13 | 2023-06-22 | 주식회사 아이바이오코리아 | 신규한 펩타이드를 포함하는 황반변성의 치료용 조성물 |
| KR102593936B1 (ko) * | 2021-12-13 | 2023-10-27 | 주식회사 아이바이오코리아 | 신규한 펩타이드를 포함하는 황반변성의 치료용 조성물 |
| KR20230089987A (ko) | 2021-12-14 | 2023-06-21 | 주식회사 아이바이오코리아 | 펩타이드 약물을 포함하는 안구 투여용 약학 조성물 |
| KR102587729B1 (ko) | 2023-02-27 | 2023-10-12 | 주식회사 아이바이오코리아 | 펩타이드를 포함하는 당뇨망막병증의 치료용 조성물 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5084555A (en) * | 1989-08-21 | 1992-01-28 | The Administrators Of The Tulane Educational Fund | An octapeptide bombesin analog |
| IT1241761B (it) * | 1990-08-03 | 1994-02-01 | Menarini Farma Ind | Peptidi di sintesi antagonisti della neurochinina a, loro sali e relativi procedimenti di fabbricazione |
| US6037135A (en) * | 1992-08-07 | 2000-03-14 | Epimmune Inc. | Methods for making HLA binding peptides and their uses |
| WO2004074312A2 (en) * | 2003-02-05 | 2004-09-02 | University Of Ulster | Tryptophyllin peptides and uses thereof |
| WO2009040087A2 (en) * | 2007-09-11 | 2009-04-02 | Mondobiotech Laboratories Ag | Therapeutic use of peptide yglf and combination with kvlpvpq |
| US10035820B2 (en) * | 2012-04-13 | 2018-07-31 | Lubrizol Advanced Materials, Inc | Compounds which inhibit neuronal exocytosis |
| KR101721059B1 (ko) * | 2014-12-26 | 2017-03-30 | 주식회사 아이바이오코리아 | 안구 표면 질환 예방 또는 치료용 약학조성물 |
| KR101798183B1 (ko) * | 2016-04-08 | 2017-11-15 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 약학조성물 |
| ES2819030T3 (es) * | 2016-04-08 | 2021-04-14 | Eyebio Korea | Péptido basado en colágeno tipo II alfa-1 útil para el tratamiento de una enfermedad de la superficie ocular |
| KR101795650B1 (ko) * | 2016-05-12 | 2017-11-09 | 인제대학교 산학협력단 | 아플리버셉트-콜라겐 타입 ii 펩타이드의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물 |
| CN109563134A (zh) * | 2016-06-28 | 2019-04-02 | 瓦勒莱塞逊－瑞彻弛有限合伙公司 | 新型环肽及其用途 |
| BR112019024040A2 (pt) * | 2017-05-17 | 2020-09-24 | Yuyu Pharma, Inc. | peptídeo e composição farmacêutica para tratamen-to de doenças oculares comprendendo o mesmo peptídeo como ingrediente ativo |
| CA3139411A1 (en) * | 2019-05-21 | 2020-11-26 | Eyebio Korea | Novel peptide compound or pharmaceutically acceptable salt thereof |
-
2020
- 2020-05-20 CA CA3139411A patent/CA3139411A1/en active Pending
- 2020-05-20 WO PCT/KR2020/006594 patent/WO2020235932A1/ko active Application Filing
- 2020-05-20 CN CN202080037370.6A patent/CN114269769A/zh active Pending
- 2020-05-20 AU AU2020277930A patent/AU2020277930B2/en active Active
- 2020-05-20 JP JP2021568962A patent/JP2022533991A/ja active Pending
- 2020-05-20 KR KR1020200060397A patent/KR20200134175A/ko not_active IP Right Cessation
- 2020-05-20 BR BR112021023477A patent/BR112021023477A2/pt unknown
- 2020-05-20 MX MX2021014051A patent/MX2021014051A/es unknown
- 2020-05-20 SG SG11202112276RA patent/SG11202112276RA/en unknown
- 2020-05-20 EP EP20808771.8A patent/EP3974441A4/en active Pending
-
2021
- 2021-11-17 ZA ZA2021/09175A patent/ZA202109175B/en unknown
-
2022
- 2022-04-29 KR KR1020220053844A patent/KR102523943B1/ko active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| MX2021014051A (es) | 2022-02-11 |
| JP2022533991A (ja) | 2022-07-27 |
| BR112021023477A2 (pt) | 2022-02-15 |
| EP3974441A1 (en) | 2022-03-30 |
| EP3974441A4 (en) | 2023-10-18 |
| KR20200134175A (ko) | 2020-12-01 |
| WO2020235932A1 (ko) | 2020-11-26 |
| ZA202109175B (en) | 2024-04-24 |
| AU2020277930A1 (en) | 2021-12-09 |
| AU2020277930B2 (en) | 2024-06-13 |
| CN114269769A (zh) | 2022-04-01 |
| CA3139411A1 (en) | 2020-11-26 |
| KR20220062252A (ko) | 2022-05-16 |
| KR102523943B1 (ko) | 2023-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202112276RA (en) | Novel peptide compound or pharmaceutically acceptable salt thereof | |
| GB201911928D0 (en) | Pharmaceutical compounds | |
| EP3480198A4 (en) | NEW COMPOUND OR ITS PHARMACEUTICALLY ACCEPTED SALT | |
| EP3705478A4 (en) | TRIAZINE COMPOUND AND PHARMACEUTICAL SALT THEREOF | |
| GB201911944D0 (en) | Pharmaceutical compounds | |
| IL290692A (en) | Salt | |
| IL288412A (en) | peptides | |
| GB201914910D0 (en) | Pharmaceutical compounds | |
| IL291570A (en) | Pharmaceutical preparations | |
| IL285144A (en) | Medicinal peptides | |
| EP3650460A4 (en) | PHARMACEUTICAL SALT OF A POLYPEPTID AND ITS USES | |
| IL290520A (en) | Medicinal peptides | |
| EP3978510A4 (en) | NOROVIRUS BINDING PEPTIDE | |
| GB201915932D0 (en) | Pharmaceutical compounds | |
| GB201915273D0 (en) | Pharmaceutical compounds | |
| EP3409662A4 (en) | NOVEL CONNECTION AND PHARMACEUTICALLY COMPATIBLE SALT OF WHICH | |
| GB201918693D0 (en) | Peptide | |
| GB201912632D0 (en) | Peptide | |
| EP4074303A4 (en) | COMPOSITION COMPRISING A P53 ACTIVATING PEPTIDE | |
| EP3936191A4 (en) | HEMAGGLUTININ BINDING PEPTIDE | |
| IL290019A (en) | Peptides to regulate melanocytes | |
| GB201914347D0 (en) | Antimicrobial peptides | |
| GB201914267D0 (en) | Pharmaceutical compounds | |
| IL311773A (en) | peptide | |
| GB201912067D0 (en) | Pharmaceutical compounds |